Pharmacolog has during this week installed a new, integrated version, of DrugLog® at the Hospital de la Santa Creu in Sant Pau in Barcelona. DrugLog® will validate preparations of chemotherapy at the hospital pharmacy and is fully integrated with the pharmacy’s and the hospital’s other software systems. The installation is a result of the collaboration between B. Braun and the purpose is to evaluate DrugLog® clinically during 2019.
During 2018, Pharmacolog have developed the DrugLog system in order to function in an integrated environment. To automatically retrieve information about drug identity and concentration from drug prescription systems greatly simplifies for the staff and the work process becomes smoother and faster. The integration has been developed through a collaboration between B. Braun S/A, IMF S/A and Pharmacolog. The IMF is the dominant supplier of software for managing cytostatic prescriptions in the Spanish market. B. Braun has supplied infusion pumps and tubing sets to St Pau and collaborates with the IMF in Spain and Latin America. The system will be evaluated clinically during 2019.
The Santa Creu Hospital in Sant Pau, Barcelona is one of Europe’s oldest hospitals and one of the leading research hospitals in Spain. The collaboration is with the hospital’s pharmacy, which is well advanced in research on drug handling.
Mats Högberg, CEO commented: “I am incredibly pleased that we, for the first time, successfully installed DrugLog® in an integrated environment. Effiecient and smooth workflow is very important in modern healthcare and our development team has worked intensively to enable DrugLog® to communicate with medical records and drug prescription systems. DrugLog now becomes a fully integrated component in an overall system for handling chemotherapy, from prescription to infusion, where DrugLog® makes it possible for the first time to really verify that the prepared solution is correct. This will have a positive effect on demand for DrugLog® in the chemotherapy segment, and we are actively working to integrate DrugLog into further similar software systems.”
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.